Evidence map›Paper›PMID 36830290›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Impact of Bacterial Infections on COVID-19 Patients: Is Timing Important?

Christos Michailides, Themistoklis Paraskevas, Iosif Karalis, Ioanna Koniari, Charalampos Pierrakos, Vasilios Karamouzos, Markos Marangos, Dimitrios Velissaris

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Christos MichailidesDepartment of Internal Medicine, University Hospital of Patras, 26223 Patras, Greece.ORCID 0000-0003-1712-9815
Themistoklis ParaskevasDepartment of Internal Medicine, University Hospital of Patras, 26223 Patras, Greece.
Iosif KaralisDepartment of Internal Medicine, University Hospital of Patras, 26223 Patras, Greece.
Ioanna KoniariCardiology Department, Liverpool Heart and Chest Hospital, Liverpool L14 3PE, UK.
Charalampos PierrakosDepartment of Intensive Care, Brugmann University Hospital, Université Libre de Bruxelles, 1050 Brussels, Belgium.
Vasilios KaramouzosIntensive Care Unit, University Hospital of Patras, 26223 Patras, Greece.ORCID 0000-0003-1122-4213
Markos MarangosDepartment of Internal Medicine, University Hospital of Patras, 26223 Patras, Greece.
Dimitrios VelissarisDepartment of Internal Medicine, University Hospital of Patras, 26223 Patras, Greece.ORCID 0000-0003-4048-740X
General University Hospital of Patras · GRUniversité Libre de Bruxelles · BEUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlong with important factors that worsen the clinical outcome of COVID-19, it has been described that bacterial infections among patients positive for a SARS-CoV-2 infection can play a dramatic role in the disease process. Co-infections or community-acquired infections are recognized within the first 48 h after the admission of patients. Superinfections occur at least 48 h after admission and are considered to contribute to a worse prognosis. Microbiologic parameters differentiate infections that happen after the fifth day of hospitalization from those appearing earlier. Specifically, after the fifth day, the detection of resistant bacteria increases and difficult microorganisms emerge.

objectivesThe aim of the study was to evaluate the impact of bacterial infections in patients with COVID-19 on the length of the hospital stay and mortality.

methodsA total of 177 patients hospitalized due to COVID-19 pneumonia were consecutively sampled during the third and fourth wave of the pandemic at a University Hospital in Greece. A confirmed bacterial infection was defined as positive blood, urinary, bronchoalveolar lavage (BAL) or any other infected body fluid. Patients with confirmed infections were further divided into subgroups according to the time from admission to the positive culture result.

resultsWhen comparing the groups of patients, those with a confirmed infection had increased odds of death (odds ratio: 3.634; CI 95%: 1.795-7.358;

conclusionIn this case series, microbial infections were an independent risk factor for a worse outcome among patients with COVID-19. Further, a correlation between the onset of infection and a negative outcome in terms of non-infected, community-acquired, early hospital-acquired and late hospital-acquired infections was identified. Late hospital-acquired infections increased the mortality of COVID-19 patients whilst superinfections were responsible for an extended length of hospital stay.

Indexed as

co-infectionsCOVID-19infection timingsuperinfections

Identifiers

PMID36830290
PMCPMC9952118
OpenAlexW4320496771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.